Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030)
Clinical trial NCT03940586 · COMPLETED
Trial details
- NCT number
- NCT03940586
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-08
- Primary completion
- 2023-01-04
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.